. 2022 Feb 5;75:103344. doi: 10.1016/j.amsu.2022.103344

Table 2.

Effects of MLC 901 on VEGF levels in rats with spinal cord injury.

Time	Administration of MLC901	VEGF ELISA		Mean Difference	P
Time	Administration of MLC901	Mean	Std. Deviation	Mean Difference	P
Before treatment	(+)	46,97	14,91	−3,65	0,74
Before treatment	(-)	50,34	16,24	−3,65	0,74
2 h after treatment	(+)	140,12	16,32	10.53	0,23
2 h after treatment	(-)	129,59	7,46	10.53	0,23
3 h after treatment (1 h after administration of MLC901)	(+)	117,04	16,53	−68,41	0,00
3 h after treatment (1 h after administration of MLC901)	(-)	185.45	15,70	−68,41	0,00
7 days after treatment	(+)	98,21	11,38	−130.5	0,00
7 days after treatment	(-)	228,71	13,94	−130.5	0,00
14 days after treatment	(+)	60,40	7,87	−91,56	0,00
14 days after treatment	(-)	152,96	15,64	−91,56	0,00

Statistical test with independent T-test, with significance p < 0.05.